I am only responding based on information supplied by doyoulikeneruda and others of his ilk. Of course it will get back to $20 share soon. Probably this coming week. All this talk of a voluntary drug recall means that Omontys will be back immediately and stronger than ever for dialysis patients, welcomed by nephrologists without so much as a hiccup, and dosing monthly at Fresenius and all of the other dialysis clinics now using old fashioned, tried and true Epogen which will be discarded. All that is necessary for this to happen is a warning label which the FDA is only too eager and happy to endorse. Cutting 75% of work force? Announcing restructuring, sale of assets, reverse merger or even bankruptcy? All bullish indicators! Better back up the truck and load those shares now so you will be rich quicker than you can say Omontys rules.
Goddy, glad to see you have a rational view. Briefly, I think "O" is fundamentally safe and can be salvaged. We have seen a savage takedown in share price in the last month. Many, many biotechs flirt with bankruptcy and AFFY will rebound, perhaps through a merger, buyout, or new partnershop agreement with Big Pharma. From a technical perspective, the last 3 days were encouraging. EOM and good night. Nev